5 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp07958 | Compound 2a | Structure in scheme 1 | Synthetic | 5c inhibits cancer via kinase blockade | Not Available | MCF-7 | Breast Cancer | IC50 = 31.64 ± 1.30 µM |
| dbacp07959 | Compound 2a | Structure in scheme 1 | Synthetic | 5c inhibits cancer via kinase blockade | Not Available | HepG-2 | Liver Cancer | IC50 = 20.37 ± 1.36 µM |
| dbacp07960 | Compound 2b | Structure in scheme 1 | Synthetic | 5c inhibits cancer via kinase blockade | Not Available | MCF-7 | Breast Cancer | IC50 = 32.58 ± 1.50 µM |
| dbacp07961 | Compound 2b | Structure in scheme 1 | Synthetic | 5c inhibits cancer via kinase blockade | Not Available | HepG-2 | Liver Cancer | IC50 = 15.80 ± 1.66 µM |
| dbacp07962 | Compound 2c | Structure in scheme 1 | Synthetic | 5c inhibits cancer via kinase blockade | Not Available | HepG-2 | Liver Cancer | IC50 = 35.52 ± 1.83 µM |